David Deri - 28 Aug 2026 Form 3 Insider Report for Turbogen Ltd. (TRBG)

Reporting relationship: Director
Issuer ticker: TRBG
Reported as of: 28 Aug 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 31 Aug 2026, 08:07:16 UTC
Source filing: View source filing
Reporting owner signature: /s/ David Deri

Key filing fact

David Deri filed Form 3 for Turbogen Ltd. (TRBG) on 31 Aug 2026.

Key facts

This page summarizes David Deri's Form 3 filing for Turbogen Ltd. (TRBG).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 31 Aug 2026, 08:07.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002123158 Primary reporting owner

Deri David

Relationship: Director
Address: 22 EFAL STREET, KIRYAT ARYEH, PETAH TIKVA, ISRAEL
Signature: /s/ David Deri
Signature date: 31 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRBG holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 36,123
Date: 28 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRBG holding Derivative

Share option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 28 Aug 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 30,177
Exercise price: $2.99
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.

Footnote F2

The options were granted with an exercise price of NIS 8.95 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $2.99 per share.